哮喘儿童家庭使用短效β受体激动剂的多中心数字化前瞻性研究
本研究在法国五家三级医院纳入120名3-11岁哮喘儿童,通过智能手机应用连接智能吸入器记录家庭沙丁胺醇使用情况6个月。43个家庭记录了124次因哮喘症状使用沙丁胺醇的事件,症状出现后2小时内中位使用3喷(IQR 2-4),仅42%的家庭用量与书面哮喘行动计划(WAAP)相似,49%用量更少。作者建议将WAAP调整为起始2-4喷、必要时重复,以更贴合家庭实践。
要点
- 哮喘症状出现后2小时内沙丁胺醇中位使用3喷(IQR 2-4,范围1-26)。
- 仅42%家庭用量与WAAP相似,49%用量少于WAAP,9%用量多于WAAP。
- 作者建议WAAP起始2-4喷、必要时重复,以更贴合家庭实践。
核心结论
- 家庭通常在哮喘症状出现后2小时内使用2-4喷沙丁胺醇,调整WAAP为起始2-4喷、必要时重复更符合家庭实践。
研究设计与样本
- 多中心观察性前瞻性研究,纳入法国五家三级医院120名3-11岁哮喘儿童,家长通过智能手机应用连接智能吸入器记录沙丁胺醇使用并回答症状问卷,持续6个月。
主要发现
- 43个家庭使用智能吸入器记录124次因哮喘症状使用沙丁胺醇的事件。
- 症状出现后2小时内沙丁胺醇中位使用3喷(IQR 2-4,范围1-26),依初始症状类型在2至4喷之间变化。
- 症状缓解与未缓解事件之间的使用喷数无显著差异。
- 18个家庭(42%)用量与WAAP相似,21个(49%)用量更少,仅4个(9%)用量更多。
临床怎么用
- 儿科医生可参考家庭实际使用2-4喷的规律,将WAAP起始剂量调整为2-4喷、必要时重复,以更贴合家庭实践。
局限性
- 仅43个家庭(120名儿童中)使用智能吸入器记录症状事件,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate real-life salbutamol use by children with asthma at home and compare it with their written asthma action plans (WAAPs). DESIGN: Multicentre, observational prospective study. SETTING: Five tertiary care hospitals in France. PATIENTS: 120 children aged 3-11 years with asthma. INTERVENTIONS: Parents used a smartphone application connected to a smart inhaler via Bluetooth to record salbutamol use and answer questionnaires about their child's asthma symptoms over 6 months. MAIN OUTCOME MEASURES: The primary outcome was the median number of salbutamol puffs used in the first 2 hours after an asthma symptom occurred, depending on symptom type. Secondary outcomes included how families operationalised WAAP instructions and the proportion who administered more or less salbutamol than prescribed. RESULTS: 43 families used the smart inhaler for asthma symptoms, recording 124 episodes of salbutamol use. The median number of puffs used in the first 2 hours was 3 (IQR 2-4, range 1-26), varying between 2 and 4 depending on the initial symptom type. The number of puffs used did not differ significantly between episodes with and without symptom resolution. 18 (42%) families used a number of salbutamol puffs similar to that in their WAAP, while 21 (49%) used fewer and only 4 (9%) used more. CONCLUSIONS: Families typically use 2-4 puffs of salbutamol in the first 2 hours after an asthma symptom. Adjusting WAAPs to start with 2-4 puffs of salbutamol, to be repeated if necessary, would be more in line with family practice, and effective in most situations. TRIAL REGISTRATION NUMBER: NCT04810169.
引用
- Gonsard A, Giovannini-Chami L, Cros P, et al. Home use of short-acting beta agonists by children with asthma: a multicentre digital prospective study. Arch Dis Child. 2025. PMID: 40169179. doi:10.1136/archdischild-2024-327447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。